Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
FPRX

Five Prime

$14.41

0.82 (6.03%)

08:51
09/13/18
09/13
08:51
09/13/18
08:51
Initiation
Five Prime initiated at Leerink »

Five Prime resumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FPRX

Five Prime

$13.09

-0.46 (-3.39%)

09:09
09/10/18
09/10
09:09
09/10/18
09:09
Hot Stocks
Five Prime completed Phase 1 safety lead-in, initiates Phase 3 of FIGHT trial »

Five Prime Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INFI

Infinity Pharmaceuticals

$2.48

0.04 (1.64%)

, NTRP

Neurotrope

$9.40

0.39 (4.33%)

07:33
09/07/18
09/07
07:33
09/07/18
07:33
Conference/Events
BioCentury to hold a conference »

25th Annual NewsMakers in…

INFI

Infinity Pharmaceuticals

$2.48

0.04 (1.64%)

NTRP

Neurotrope

$9.40

0.39 (4.33%)

TNXP

Tonix Pharmaceuticals

$1.02

-0.02 (-1.92%)

ARCT

Arcturus Therapeutics

$7.91

-0.06 (-0.75%)

OVID

Ovid Therapeutics

$6.09

-0.23 (-3.64%)

OBSV

ObsEva

$13.57

0.02 (0.15%)

EIGR

Eiger BioPharmaceuticals

$12.50

-0.3 (-2.34%)

BSTC

BioSpecifics

$54.33

-0.21 (-0.39%)

TPIV

TapImmune

$9.18

-0.47 (-4.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Sep

FPRX

Five Prime

$14.15

0.17 (1.22%)

17:26
09/04/18
09/04
17:26
09/04/18
17:26
Hot Stocks
Breaking Hot Stocks news story on Five Prime »

Biotechnology Value Fund…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

Over a month ago
FPRX

Five Prime

$15.46

0.07 (0.45%)

08:08
08/09/18
08/09
08:08
08/09/18
08:08
Recommendations
Five Prime analyst commentary at Wells Fargo »

Five Prime price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FPRX

Five Prime

$15.46

0.07 (0.45%)

16:33
08/08/18
08/08
16:33
08/08/18
16:33
Earnings
Five Prime reports Q2 EPS (99c), consensus ($1.29) »

Reports Q2 revenue $7.6M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

INFI

Infinity Pharmaceuticals

$1.86

0.06 (3.33%)

15:48
08/07/18
08/07
15:48
08/07/18
15:48
Earnings
Infinity Pharmaceuticals reports Q2 EPS (12c), consensus (20c) »

As of June 30, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

INFI

Infinity Pharmaceuticals

$1.80

-0.02 (-1.10%)

, AGIO

Agios Pharmaceuticals

$79.81

0.95 (1.20%)

08:37
08/07/18
08/07
08:37
08/07/18
08:37
Hot Stocks
Infinity Pharmaceuticals appoints Samuel Agresta as Chief Medical Officer »

Infinity Pharmaceuticals…

INFI

Infinity Pharmaceuticals

$1.80

-0.02 (-1.10%)

AGIO

Agios Pharmaceuticals

$79.81

0.95 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 13

    Aug

  • 21

    Aug

FPRX

Five Prime

$16.80

-0.98 (-5.51%)

08:51
06/28/18
06/28
08:51
06/28/18
08:51
Initiation
Five Prime initiated at Raymond James »

Five Prime initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCUS

Arcus Biosciences

$14.65

-0.7 (-4.56%)

, INFI

Infinity Pharmaceuticals

$2.04

(0.00%)

08:43
06/26/18
06/26
08:43
06/26/18
08:43
Hot Stocks
Infinity Pharmaceuticals announce clinical collaboration to evaluate therapies »

Arcus Biosciences (RCUS)…

RCUS

Arcus Biosciences

$14.65

-0.7 (-4.56%)

INFI

Infinity Pharmaceuticals

$2.04

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.